Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 2016

Date: 2016-02

DelveInsight Report, “Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 2016” emphasizes on the novel bispecific antibodies technologies in research and development. The report enlists company, target antigens, phase and indication specific R&D pipelines of Bispecifc Antibodies (bsAbs). It includes information about 18 companies with 41 products in pipeline based on 19 different technologies. The report also covers other commercial aspects such as the market assessment of the pipeline drugs, future drugs approval timeline, current and future pipeline scenario. The report also provides the detailed analysis on barriers and drivers.
Report Highlights:
• Bispecific Antibodies Market Assessment
• Bispecific Antibodies Pipeline scenario
• Historical Technology timeline & Novel technologies
• Current Prominent Research Areas and Key Players
• Market Drivers and Barriers
• Overview of the global Bispecific antibodies pipeline and marketed scenario, products and associated companies information
• Coverage of global Bispecific antibody therapies under development
• Competitive landscape of products for key players and related indications
• Coverage of licensors, collaborators and Development partners
• Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities
• Highlights of Novel Bispecifc Antibodies technologies and innovative companies
• Key topics covered include strategic competitor assessment, barriers and drivers in the market


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample